[1]
K. Mokhnache, “Topical Anti-inflammatory evaluation of new hydrazone: 4-chloro-3-nitrobenzylidene) isonicotinohydrazide: Topical Anti-inflammatory evaluation”, J. Drug Delivery Ther., vol. 9, no. 5-s, pp. 1–3, Oct. 2019, doi: 10.22270/jddt.v9i5-s.3433.